Labels
Breast Cancers
(143)
Genitourinary Cancers
(71)
Lung Cancers
(70)
Gastrointestinal Cancers
(66)
Gynecological Cancers
(55)
Head and Neck Cancers
(49)
Cutaneous Cancers
(21)
Central Nervous System Cancers
(11)
Wednesday 6 February 2013
Proposed change to rodent carcinogenicity testing of pharmaceuticals - regulatory notice for public input
A change to the current ICH S1 guidance on rodent carcinogenicity testing is being considered. The goal of this potential change is to introduce a more comprehensive and integrated approach to address the risk of human carcinogenicity of small molecule pharmaceuticals, and to define conditions under which 2-yr rodent carcinogenicity studies add value to that assessment. Read more here.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment